https://www.selleckchem.com/pr....oducts/oicr-9429.htm
05-1.51) for major malformations, and 1.59 (95 % confidence interval 1.02-2.49) for cardiac malformations. In conclusion, methylphenidate exposure in early pregnancy is associated with a small but significant increased risk for major malformations, which can be attributed mostly to increased risk of cardiac malformations. It may be advisable to consider fetal echocardiography in pregnant women using methylphenidate during pregnancy. INTRODUCTION The role of surgical drainage versus conservative therapy in treating patients with paraph
Like
Comment
Share
